Log in to save to my catalogue

Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of...

Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571765

Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database

About this item

Full title

Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database

Publisher

Hoboken, USA: John Wiley & Sons, Inc

Journal title

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.e2034-e2041

Language

English

Formats

Publication information

Publisher

Hoboken, USA: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
We externally validated Fujimoto's post‐transplant lymphoproliferative disorder (PTLD) scoring system for risk prediction by using the Taiwan Blood and Marrow Transplant Registry Database (TBMTRD) and aimed to create a superior scoring system using machine learning methods.
Materials and Methods
Consecutive allogeneic hematopoie...

Alternative Titles

Full title

Validation of a Post‐Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571765

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8571765

Other Identifiers

ISSN

1083-7159

E-ISSN

1549-490X

DOI

10.1002/onco.13969

How to access this item